|
BCOR expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.35769983933676E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.55950000002569E-06 |
| Normal-vs-Stage2 |
8.177900E-04 |
| Normal-vs-Stage3 |
7.88770000426098E-08 |
| Normal-vs-Stage4 |
4.33860000148556E-08 |
| Stage1-vs-Stage2 |
9.122800E-01 |
| Stage1-vs-Stage3 |
2.013000E-01 |
| Stage1-vs-Stage4 |
7.496100E-02 |
| Stage2-vs-Stage3 |
3.726000E-01 |
| Stage2-vs-Stage4 |
2.032600E-01 |
| Stage3-vs-Stage4 |
5.866200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.54629999599743E-08 |
| Normal-vs-AfricanAmerican |
1.226060E-04 |
| Normal-vs-Asian |
6.891400E-01 |
| Caucasian-vs-AfricanAmerican |
9.063000E-01 |
| Caucasian-vs-Asian |
5.680500E-02 |
| AfricanAmerican-vs-Asian |
1.294590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.41049996314069E-09 |
| Normal-vs-Female |
1.032850E-04 |
| Male-vs-Female |
2.299200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.75440000030436E-07 |
| Normal-vs-Age(41-60Yrs) |
7.47549999680075E-08 |
| Normal-vs-Age(61-80Yrs) |
2.06179999739931E-08 |
| Normal-vs-Age(81-100Yrs) |
9.370600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.682000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.676000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.038600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.375400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.424400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.752800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.690200E-01 |
| Normal-vs-Grade 2 |
1.72841999999118E-05 |
| Normal-vs-Grade 3 |
5.89449999921499E-09 |
| Normal-vs-Grade 4 |
2.22800000670986E-10 |
| Grade 1-vs-Grade 2 |
8.758000E-02 |
| Grade 1-vs-Grade 3 |
2.905800E-02 |
| Grade 1-vs-Grade 4 |
5.847900E-04 |
| Grade 2-vs-Grade 3 |
7.616500E-02 |
| Grade 2-vs-Grade 4 |
2.629400E-04 |
| Grade 3-vs-Grade 4 |
3.076100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.043230E-03 |
| Normal-vs-ccB subtype |
4.01500055424719E-10 |
| ccA subtype-vs-ccB subtype |
3.31280000098744E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.01720000037042E-07 |
| Normal-vs-N1 |
3.620200E-04 |
| N0-vs-N1 |
1.500590E-01 |
|
|
